Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for CKD progression in ADPKD
NCT01009957Phase 3Terminated
- Sponsor
- Ospedale Alessandro Manzoni
- Start
- Jun 2008
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Ospedale Alessandro Manzoni. Started Jun 2008; status: terminated.
02
Drugs
everolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT01009957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009957.